The Food and Drug Administration (FDA) has approved onabotulinumtoxin A for adult patients who suffer headaches on 15 or more days per month, lasting more than 4 hours. News, Medscape Medical News, October 2010

This entry was posted in Neuro-Ophthalmology. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

* Copy This Password *

* Type Or Paste Password Here *

What is 14 + 5 ?
Please leave these two fields as-is:
IMPORTANT! To be able to proceed, you need to solve the following simple math (so we know that you are a human) :-)
Maryland Center for Neuro-Ophthalmology and Neuro-Otology
Skip to toolbar